MoneyWorks4Me

Morepen Laboratories - Quaterly Results

16 May 2023 Evaluate
Revenue reduced marginally to stand at Rs. 3365.24 millions during the quarter ended March 2023. The figure stood at Rs. 3424.42 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 102.75  millions from Rs. 142.74 millions ,decline by -28.02%.Operating profit for the quarter ended March 2023 decreased to 181.17 millions as compared to 222.87 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3365.24 3424.42 -1.73 13388.83 14492.67 -7.62 13388.83 14492.67 -7.62
Other Income 29.88 31.08 -3.86 57.59 102.35 -43.73 57.59 102.35 -43.73
PBIDT 181.17 222.87 -18.71 830.29 1393.72 -40.43 830.29 1393.72 -40.43
Interest 5.62 7.96 -29.40 19.81 -73.66 -126.89 19.81 -73.66 -126.89
PBDT 175.55 214.91 -18.31 810.48 1467.38 -44.77 810.48 1467.38 -44.77
Depreciation 46.14 48.20 -4.27 180.06 211.95 -15.05 180.06 211.95 -15.05
PBT 129.41 166.71 -22.37 630.42 1255.43 -49.78 630.42 1255.43 -49.78
TAX 26.66 23.97 11.22 167.99 244.82 -31.38 167.99 244.82 -31.38
Deferred Tax 2.03 24.83 -91.82 2.03 24.83 -91.82 2.03 24.83 -91.82
PAT 102.75 142.74 -28.02 462.43 1010.61 -54.24 462.43 1010.61 -54.24
Equity 1022.27 955.59 6.98 1022.27 955.59 6.98 1022.27 955.59 6.98
PBIDTM(%) 5.38 6.51 -17.28 6.20 9.62 -35.51 6.20 9.62 -35.51
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..